Literature DB >> 2998841

Cell configuration and adhesive properties of metastasizing and non-metastasizing BSp73 rat adenocarcinoma cells.

A Raz, M Zöller.   

Abstract

The pattern of cell substrate interaction, the cell surface composition and the organization of cytoskeletal elements was studied in tumour cell variants of the BSp73 rat adenocarcinoma displaying different metastatic capabilities and cell configuration. The non-metastasizing AS variant cells adhered to the substrate and spread via vinculin-containing focal contacts. These cells also synthesized, secreted and assembled fibronectin at the pericellular area. The metastasizing ASML variant cells adhered to the substrate at a slower rate via thick cytoplasmic protrusions, but were removed from the substrate by trypsin-EDTA slower than the non-metastasizing AS variant cells. The ASML cells also synthesized very low levels of both vinculin and fibronectin, displayed a diffuse pattern of actin and tubulin organization, and were unable to spread on the substrate. Spreading could not be induced in the ASML cells by seeding the cells on an extracellular matrix derived from bovine corneal endothelial cells or on concanavalin A (conA)-coated substrates, or by the addition of db-cAMP to the medium. The metastasizing cells expressed a unique and abundant cell surface glycoprotein of Mr 170 000 which was also shed into the growth medium. The relationships among the adhesive properties, the organization of cell surface components and of the cytoskeleton in the tumour cell variants, and the expression of their metastatic phenotype is discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2998841     DOI: 10.1016/0014-4827(86)90431-3

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  15 in total

Review 1.  Tissue culture in the study of cancer.

Authors:  S Casillo; A La Pera; L Frati
Journal:  Cytotechnology       Date:  1990-03       Impact factor: 2.058

2.  Cell migration and actin organization in cultured human primary, recurrent cutaneous and metastatic melanoma. Time-lapse and image analysis.

Authors:  H R Byers; T Etoh; J R Doherty; A J Sober; M C Mihm
Journal:  Am J Pathol       Date:  1991-08       Impact factor: 4.307

3.  The regulation of cyclic AMP production and the role of cyclic AMP in B16 melanoma cells of differing metastatic potential.

Authors:  S E Hill; R C Rees; S MacNeil
Journal:  Clin Exp Metastasis       Date:  1990 Sep-Oct       Impact factor: 5.150

Review 4.  Cell-contact and -architecture of malignant cells and their relationship to metastasis.

Authors:  A Raz; A Ben-Ze'ev
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

5.  Effect of lovastatin alone and as an adjuvant chemotherapeutic agent on hepatoma tissue culture-4 cell growth.

Authors:  T J Morris; S L Palm; L L Furcht; H Buchwald
Journal:  Ann Surg Oncol       Date:  1995-05       Impact factor: 5.344

6.  Vinculin regulates cell-surface E-cadherin expression by binding to beta-catenin.

Authors:  Xiao Peng; Laura E Cuff; Cort D Lawton; Kris A DeMali
Journal:  J Cell Sci       Date:  2010-01-19       Impact factor: 5.285

7.  Substrate adhesiveness and experimental metastatic potential of rat ascites hepatoma AH7974-derived variant sublines.

Authors:  T Kawaguchi; S Igarashi; H Wakabayashi; S Yokoya; K Fukui
Journal:  Clin Exp Metastasis       Date:  1992-07       Impact factor: 5.150

8.  Changes in adhesive properties of tumor cells do not necessarily influence metastasizing capacity.

Authors:  M Zöller; S Matzku
Journal:  Clin Exp Metastasis       Date:  1989 Mar-Apr       Impact factor: 5.150

9.  Suppression of tumorigenicity in simian virus 40-transformed 3T3 cells transfected with alpha-actinin cDNA.

Authors:  U Glück; D J Kwiatkowski; A Ben-Ze'ev
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

10.  Prevention of tumor metastasis formation by anti-variant CD44.

Authors:  S Seiter; R Arch; S Reber; D Komitowski; M Hofmann; H Ponta; P Herrlich; S Matzku; M Zöller
Journal:  J Exp Med       Date:  1993-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.